Published in Clin Infect Dis on November 01, 2009
A randomized clinical trial of the immunogenicity of 7-valent pneumococcal conjugate vaccine compared to 23-valent polysaccharide vaccine in frail, hospitalized elderly. PLoS One (2014) 0.84
Is there a potential role for protein-conjugate pneumococcal vaccine in older adults? Australas Med J (2012) 0.78
Conjugate and 23-valent pneumococcal polysaccharide booster vaccination in asplenic patients with thalassemia major: A randomized clinical trial study. Caspian J Intern Med (2017) 0.75
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet (2010) 13.86
Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med (2006) 11.49
Global burden of childhood pneumonia and diarrhoea. Lancet (2013) 9.28
Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet (2009) 4.81
The Pneumonia Etiology Research for Child Health Project: a 21st century childhood pneumonia etiology study. Clin Infect Dis (2012) 3.40
Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. Bull World Health Organ (2005) 3.36
Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries. J Glob Health (2013) 3.30
Report from a WHO Working Group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae. Pediatr Infect Dis J (2003) 3.29
Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med (2010) 3.25
Revisiting pneumococcal carriage by use of broth enrichment and PCR techniques for enhanced detection of carriage and serotypes. J Clin Microbiol (2010) 2.79
The fundamental link between pneumococcal carriage and disease. Expert Rev Vaccines (2012) 2.79
Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members. Clin Infect Dis (2008) 2.72
Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Med (2013) 2.54
Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis (2010) 2.50
Maternal influenza vaccination and effect on influenza virus infection in young infants. Arch Pediatr Adolesc Med (2010) 2.47
Pneumococcal vaccination in developing countries. Lancet (2006) 2.45
Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine. Clin Infect Dis (2008) 2.22
Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies. Vaccine (2007) 2.07
Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease. Clin Infect Dis (2010) 2.03
Epidemiology of invasive Haemophilus influenzae type A disease among Navajo and White Mountain Apache children, 1988-2003. Clin Infect Dis (2005) 2.01
Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination. J Pediatr (2003) 2.00
Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques. PLoS One (2013) 1.84
Effects of vaccination on invasive pneumococcal disease in South Africa. N Engl J Med (2014) 1.84
Seasonal drivers of pneumococcal disease incidence: impact of bacterial carriage and viral activity. Clin Infect Dis (2013) 1.81
The definition of pneumonia, the assessment of severity, and clinical standardization in the Pneumonia Etiology Research for Child Health study. Clin Infect Dis (2012) 1.78
The burden of acute respiratory infections in crisis-affected populations: a systematic review. Confl Health (2010) 1.72
Nasopharyngeal versus oropharyngeal sampling for detection of pneumococcal carriage in adults. J Clin Microbiol (2004) 1.58
Association of the pneumococcal pilus with certain capsular serotypes but not with increased virulence. J Clin Microbiol (2007) 1.51
Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in Native American communities. J Infect Dis (2011) 1.51
Effect of vaccines on bacterial meningitis worldwide. Lancet (2012) 1.50
Effect of community-wide conjugate pneumococcal vaccine use in infancy on nasopharyngeal carriage through 3 years of age: a cross-sectional study in a high-risk population. Clin Infect Dis (2006) 1.47
Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics (2002) 1.47
Strain characteristics of Streptococcus pneumoniae carriage and invasive disease isolates during a cluster-randomized clinical trial of the 7-valent pneumococcal conjugate vaccine. J Infect Dis (2007) 1.43
Laboratory methods for determining pneumonia etiology in children. Clin Infect Dis (2012) 1.38
Identification and selection of cases and controls in the Pneumonia Etiology Research for Child Health project. Clin Infect Dis (2012) 1.33
Breathing new life into pneumonia diagnostics. J Clin Microbiol (2009) 1.28
Specimen collection for the diagnosis of pediatric pneumonia. Clin Infect Dis (2012) 1.26
Impact of immunizations on the disease burden of American Indian and Alaska native children. Arch Pediatr Adolesc Med (2009) 1.24
Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type nasopharyngeal carriage. Pediatr Infect Dis J (2014) 1.24
Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia. Pediatr Infect Dis J (2014) 1.23
Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type invasive pneumococcal disease among young children. Pediatr Infect Dis J (2014) 1.22
A literature review and survey of childhood pneumonia etiology studies: 2000-2010. Clin Infect Dis (2012) 1.21
The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease. Lancet Infect Dis (2007) 1.19
Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization. Pediatr Infect Dis J (2014) 1.18
The burden of childhood pneumonia in the developed world: a review of the literature. Pediatr Infect Dis J (2013) 1.15
Immunoblot method to detect Streptococcus pneumoniae and identify multiple serotypes from nasopharyngeal secretions. J Clin Microbiol (2004) 1.14
Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus. J Infect Dis (2008) 1.14
Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on immunogenicity. Pediatr Infect Dis J (2014) 1.12
Standardizing surveillance of pneumococcal disease. Clin Infect Dis (2009) 1.12
Pre- and post-conjugate vaccine epidemiology of pneumococcal serotype 6C invasive disease and carriage within Navajo and White Mountain Apache communities. Clin Infect Dis (2010) 1.10
Invasive pneumococcal disease epidemiology and effectiveness of 23-valent pneumococcal polysaccharide vaccine in Alaska native adults. Vaccine (2006) 1.10
Using pneumococcal carriage data to monitor postvaccination changes in invasive disease. Am J Epidemiol (2013) 1.09
Nasopharyngeal carriage of Streptococcus pneumoniae in Navajo and White Mountain Apache children before the introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J (2009) 1.08
Evaluation of risk factors for severe pneumonia in children: the Pneumonia Etiology Research for Child Health study. Clin Infect Dis (2012) 1.07
The role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease. Pediatr Infect Dis J (2008) 1.03
Comparative immunogenicity of 7 and 13-valent pneumococcal conjugate vaccines and the development of functional antibodies to cross-reactive serotypes. PLoS One (2013) 1.02
Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers. Pediatr Infect Dis J (2014) 1.01
Use and evaluation of molecular diagnostics for pneumonia etiology studies. Clin Infect Dis (2012) 1.00
Effectiveness of the 23-valent polysaccharide vaccine against invasive pneumococcal disease in Navajo adults. J Infect Dis (2003) 1.00
A policy framework for accelerating adoption of new vaccines. Hum Vaccin (2010) 0.98
Disk diffusion bioassays for the detection of antibiotic activity in body fluids: applications for the Pneumonia Etiology Research for Child Health project. Clin Infect Dis (2012) 0.97
Nontypeable pneumococcal isolates among navajo and white mountain apache communities: are these really a cause of invasive disease? J Infect Dis (2012) 0.95
PCV13 impact evaluations: the obvious and the unpredicted. Pediatr Infect Dis J (2013) 0.95
Competition between Streptococcus pneumoniae strains: implications for vaccine-induced replacement in colonization and disease. Epidemiology (2013) 0.94
Could a single dose of pneumococcal conjugate vaccine in children be effective? Modeling the optimal age of vaccination. Vaccine (2005) 0.93
Procedures for collection of induced sputum specimens from children. Clin Infect Dis (2012) 0.93
Modeling the association between pneumococcal carriage and child-care center attendance. Clin Infect Dis (2005) 0.92
Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine. Clin Infect Dis (2007) 0.92
Risk factors for invasive pneumococcal disease among Navajo adults. Am J Epidemiol (2007) 0.92
Methods for a systematic review of pneumococcal conjugate vaccine dosing schedules. Pediatr Infect Dis J (2014) 0.89
Pneumonia etiology research for child health. Introduction. Clin Infect Dis (2012) 0.89
The differential impact of coadministered vaccines, geographic region, vaccine product and other covariates on pneumococcal conjugate vaccine immunogenicity. Pediatr Infect Dis J (2014) 0.88
Impact of intrapartum antibiotics on the care and evaluation of the neonate. Pediatr Infect Dis J (2003) 0.87
Respiratory syncytial virus infection in Navajo and White Mountain Apache children. Pediatrics (2002) 0.86
The epidemiologic evidence underlying recommendations for use of pneumococcal polysaccharide vaccine among American Indian and Alaska Native populations. Vaccine (2011) 0.86
Evaluation of fast-track diagnostics and TaqMan array card real-time PCR assays for the detection of respiratory pathogens. J Microbiol Methods (2014) 0.86
Invasive pneumococcal disease among Navajo adults, 1989-1998. Clin Infect Dis (2004) 0.85
Pneumococcal sequence type replacement among American Indian children: a comparison of pre- and routine-PCV7 eras. Vaccine (2011) 0.85
Review of guidelines for evidence-based management for childhood community-acquired pneumonia in under-5 years from developed and developing countries. Pediatr Infect Dis J (2013) 0.82
Contributions of Native Americans to the global control of infectious diseases. Vaccine (2006) 0.82
Delivering pneumococcal vaccine to a high risk population: the Navajo experience. Hum Vaccin (2005) 0.78
Invasive pneumococcal disease among White Mountain Apache adults, 1991-2005. Arch Intern Med (2008) 0.78
Global Burden of Neonatal Invasive Pneumococcal Disease: A Systematic Review and Meta-analysis. Pediatr Infect Dis J (2016) 0.77
Efficacy of a pentavalent human-bovine reassortant rotavirus vaccine against rotavirus gastroenteritis among American Indian children. Pediatr Infect Dis J (2012) 0.77
Relating Pneumococcal Carriage Among Children to Disease Rates Among Adults Before and After the Introduction of Conjugate Vaccines. Am J Epidemiol (2016) 0.76
A prospective study of agents associated with acute respiratory infection among young American Indian children. Pediatr Infect Dis J (2013) 0.75
Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage Among American Indians. Pediatr Infect Dis J (2016) 0.75
Is pneumonia among children in developing countries a different disease from the 1 among patients in the same age group in developed countries? Pediatr Infect Dis J (2014) 0.75
Optimizing the use of pneumococcal conjugate vaccine globally. JAMA (2013) 0.75
Persistence of IgG antibody following routine infant immunization with the 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J (2015) 0.75
Integrated monitoring of a new group B streptococcal disease prevention program and other perinatal infections. Matern Child Health J (2002) 0.75